IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.20
+0.01 (+5.82%)
As of Nov 7, 2:43 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.13M
Net Income
-5,366,895
Gross Margin
34.2%
Profit Margin
-477.1%
Rev Growth
-1.5%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.13M 1.14M 13.95M 13.36M
Gross Profit 384.9K 390.9K 8.05M 7.71M
Operating Income -10,037,640 -9,173,310 2.14M 2.33M
Net Income -5,366,895 -4,904,757 2.16M 1.76M
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Rev Growth -1.5% -1.5% +17.1% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 204.3K 204.3K 9.96M 10.38M
Total Equity 11.29M 11.29M 19.20M 17.06M
D/E Ratio 0.02 0.02 0.52 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,596,055 -9,256,958 3.52M 3.64M
Free Cash Flow — — 2.06M 1.63M